Innate Pharma SA(GB:0EVI)
€1.29-0.03 (-2.57%)
GB:0EVI
Innate Pharma SA financials statements
€1.29
At close:-0.03 (-2.57%)
Innate Pharma SA (0EVI) Income Statement
0 Followers
Innate Pharma SA Income Statement
Last quarter (Q2 2026), Innate Pharma SA's total revenue was €3.12M, a decrease of 74.77% from the same quarter last year. In Q2, Innate Pharma SA's net income was €-19.62M. See Innate Pharma SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 2.79M | € 12.62M | € 51.90M | € 49.64M | € 12.11M | |
| € 2.79M | € -31.86M | € 5.62M | € 6.01M | € -34.89M | |
| € 56.21M | € 19.72M | € 18.29M | € 63.44M | € 25.52M | |
| Depreciation and Amortization | € 1.38M | € 1.99M | € 5.09M | € 4.42M | € 4.60M |
| € -55.97M | € -50.99M | € -1.84M | € -61.30M | € -43.23M | |
| € -57.36M | € -51.58M | € -12.67M | € -24.63M | € -47.83M | |
| € 1.98M | € 2.10M | € 5.10M | € -547.00K | € 2.35M | |
| € -55.38M | € -56.96M | € -7.57M | € -57.97M | € -45.48M | |
| € -49.18M | € -49.47M | € -7.57M | € -58.10M | € -52.81M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.55 | € -0.61 | € -0.09 | € -0.73 | € -0.74 |
| Diluted EPS | € -0.55 | € -0.61 | € -0.09 | € -0.73 | € -0.66 |
| Weighted Average Shares Outstanding | 89.41M | 60.93M | 60.93M | 60.93M | 60.93M |
| Weighted Average Shares Outstanding (Diluted) | 89.41M | 81.05M | 80.45M | 79.64M | 79.54M |
Currency in EUR
